HuagongsheHuagongshe Chemistry Print Report · For research reference only
Salbutamol → [(1,1-Dimethylethyl)(phenylmethyl)-amino]acetyl-2-hydroxybenzoate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Salbutamol | HCID 2083 | — |
| Reactant | Acetophenone | HCID 7410 | — |
| Reactant | N-(1,1-Dimethylethyl)benzenemethanamine | HCID 76908 | — |
| Reactant | Bromoacetyl-2-hydroxybenzoate | HCID 21684415 | — |
| Product | [(1,1-Dimethylethyl)(phenylmethyl)-amino]acetyl-2-hydroxybenzoate | HCID 86744191 | — |
Reaction Steps
Albuterol has been prepared, see Irish Patent Specification No. 31391, Aug. 9, 1972, starting from the appropriate acetophenone derivative methyl-5-(bromoacetyl-2-hydroxybenzoate, by condensation with N-(1,1-dimethylethyl)benzenemethanamine in the presence of base to form the ketonic ester, methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl-2-hydroxybenzoate. The ketonic ester is reduced with lithium aluminum hydride in tetrahydrofuran under nitrogen to yield α1-[[(1,1-dimethylethyl)-(phenylmethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol which is subsequently debenzylated with hydrogen in the presence of palladium on carbon catalyst to produce albuterol.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04952729 |
| Source dataset | uspto-grants-1990_08 |
| ORD ID | ord-a7ee21119a7b4553868bb6ad80262184 |
| Source note | uspto-grants-1990_08 |